Crawford Scientific, a UK-based supplier of scientific products and technical support services partners, received a £3.9m investment from Maven Capital Partners.
Maven has invested alongside founder Sam Crawford and the senior management team, as part of a strategic plan to grow the business in the UK and internationally. The investment will allow Crawford to pursue its organic growth strategy with an emphasis on its service offering, develop new markets and look at strategic acquisition opportunities.
As part of the transaction, Sean Kerr will join the board as Chairman.
Established in 1985 and with a turnover now in excess of £10m, Crawford provides chromatography consumables, instrument parts and technical services to a wide range of industries including the pharmaceutical and oil & gas sectors. Its range of technical support services which includes training, e-learning, analytical services, IT solutions and consultancy.
Located in Strathaven, 15 miles south of Glasgow, the business supplies laboratories across the UK, mainland Europe and the USA. Customers include a number of blue-chip clients such as GlaxoSmithKline, AstraZeneca and BP.
FinSMEs